Russia says medics to get anti-Covid shots in two weeks, rejects safety concerns | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
July 03, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JULY 03, 2025
Russia says medics to get anti-Covid shots in two weeks, rejects safety concerns

Coronavirus chronicle

Reuters
12 August, 2020, 04:00 pm
Last modified: 12 August, 2020, 04:02 pm

Related News

  • Syria receives first shipment of Russian shots - report
  • Young Pakistanis rush to purchase Russian vaccine as private sales open
  • Africa proves rocky terrain for Russian and Chinese vaccines
  • EU says no talks under way to buy Russia's Covid-19 vaccine
  • EU regulator says Russia yet to submit Covid-19 vaccine application

Russia says medics to get anti-Covid shots in two weeks, rejects safety concerns

The vaccine has not yet completed its final trials. Only about 10 percent of clinical trials are successful and some scientists fear Moscow may be putting national prestige before safety

Reuters
12 August, 2020, 04:00 pm
Last modified: 12 August, 2020, 04:02 pm
FILE PHOTO: A man rides a bicycle along empty Red Square near St. Basil's Cathedral in central Moscow, Russia May 1, 2020. Russia marks the Spring and Labour Day without traditional demonstrations and celebrations due to the coronavirus disease (Covid-19) outbreak. REUTERS/Shamil Zhumatov/File Photo
FILE PHOTO: A man rides a bicycle along empty Red Square near St. Basil's Cathedral in central Moscow, Russia May 1, 2020. Russia marks the Spring and Labour Day without traditional demonstrations and celebrations due to the coronavirus disease (Covid-19) outbreak. REUTERS/Shamil Zhumatov/File Photo

Russia said on Wednesday the first batch of its Covid-19 vaccine would be ready for some medics within two weeks and rejected as "groundless" safety concerns aired by some experts over Moscow's rapid approval of the drug.

President Vladimir Putin said on Tuesday that Russia had become the first country to grant regulatory approval to a Covid-19 vaccine, after less than two months of human testing.

The vaccine has not yet completed its final trials. Only about 10 percent of clinical trials are successful and some scientists fear Moscow may be putting national prestige before safety.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"It seems our foreign colleagues are sensing the specific competitive advantages of the Russian drug and are trying to express opinions that in our opinion are completely groundless," Health Minister Mikhail Murashko said on Wednesday.

He said the vaccine developed by Moscow's Gamaleya Institute would be administered to people, including doctors, on a voluntary basis, and would be ready soon.

"The first packages of the medical vaccine against the coronavirus infection will be received within the next two weeks, primarily for doctors," he said.

Alexander Gintsburg, director of the Gamaleya Institute, said clinical trials would be published once they have been assessed by Russia's own experts.

He said Russia plans to be able to produce 5 million doses a month by December-January.

Kazakhstan plans to send government officials to Moscow later this month to discuss possible deliveries of the vaccine, its presidential office said.

Russian Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A file photo of Colonel Md Shafiqul Islam of the Directorate of Military Operations briefing media. Photo: UNB
    Strict action if army personnel found involved in enforced disappearances: Army HQ
  • Office of the Anti-Corruption Commission. File Photo: TBS
    ACC launches probe against 2 more NBR commissioners, 3 other officials
  • Graphics: TBS
    Foreign currency in offshore banking units now eligible as collateral for taka loans: Central bank

MOST VIEWED

  • Chief adviser’s Special Envoy for International Affairs and Adviser Lutfey Siddiqi
    Fake documents submission behind visa complications for Bangladeshis: Lutfey Siddiqi
  • Electric power transmission pylon miniatures and Adani Green Energy logo are seen in this illustration taken, on 9 December 2022. Photo: Reuters
    Bangladesh clears all dues to Adani Power
  • A file photo of the NBR Bhaban in Agargaon, Dhaka
    NBR officers gripped by fear as govt gets tough  
  • Controversial taxman Matiur’s rulings cost govt Tk1000cr in lost revenue
    Controversial taxman Matiur’s rulings cost govt Tk1000cr in lost revenue
  • History in women's football: Bangladesh qualify for Asian Cup for the first time
    History in women's football: Bangladesh qualify for Asian Cup for the first time
  • NBR Office in Dhaka. File Photo: Collected
    Govt sends 4 senior NBR officials on forced retirement

Related News

  • Syria receives first shipment of Russian shots - report
  • Young Pakistanis rush to purchase Russian vaccine as private sales open
  • Africa proves rocky terrain for Russian and Chinese vaccines
  • EU says no talks under way to buy Russia's Covid-19 vaccine
  • EU regulator says Russia yet to submit Covid-19 vaccine application

Features

Illustration: TBS

The buildup to July Uprising: From a simple anti-quota movement to a wildfire against autocracy

20h | Panorama
Illustration: TBS

Ulan Daspara: Remnants of a fishing village in Dhaka

2d | Panorama
Photo: Collected

Innovative storage accessories you’ll love

4d | Brands
Two competitors in this segment — one a flashy newcomer, the other a hybrid veteran — are going head-to-head: the GAC GS3 Emzoom and the Toyota CH-R. PHOTOS: Nafirul Haq (GAC Emzoom) and Akif Hamid (Toyota CH-R)

GAC Emzoom vs Toyota CH-R: The battle of tech vs trust

4d | Wheels

More Videos from TBS

Why is the US dollar falling to a record low in 2025?

Why is the US dollar falling to a record low in 2025?

33m | Others
Trump calls on US central bank head to quit immediately

Trump calls on US central bank head to quit immediately

53m | TBS World
Tazia procession safe and secure; assures administration

Tazia procession safe and secure; assures administration

1h | TBS Today
India is going to sign a 10-year defense agreement with the United States

India is going to sign a 10-year defense agreement with the United States

1h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net